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Abstract. Malaria remains a public health crisis in areas where it has resisted control efforts. In Nchelenge District, a
high-transmission area in northern Zambia, malaria accounts for more than one-third of pediatric hospitalizations and
nearly one-half of hospital deaths in children. To identify risk factors for death due to malaria, we conducted a retrospective, time-matched case-control study of 126 children hospitalized with malaria who died (cases) and 126 children
who survived (controls). There were no differences in age, gender, hemoglobin concentration, or prevalence of severe
anemia between cases and controls. Children who died were more likely to come from villages located at greater
distances from the hospital than children who survived (median 13.5 versus 3.2 km). Each additional kilometer of distance
from the hospital increased the odds of death by 4% (odds ratio 1.04, 95% conﬁdence interval 1.01–1.07, P < 0.01). Extent
of anemia and admission during periods when blood was unavailable for transfusion were associated with early death (P £
0.03). Delays in initiation of treatment of severe malaria contribute to the increased odds of death in children referred from
more distant health centers, and might be mitigated by transportation improvements, capacity at rural health posts to
administer treatment before transfer, hospital triage systems that minimize time to treatment, and reliable blood product
stores at referral hospitals.

INTRODUCTION

anticonvulsants, and ventilator and vasopressor support), but
even with appropriate care, mortality can reach 20%.5 Delayed
presentation to allopathic health providers on account of logistical constraints or health-seeking behaviors compounds the danger.7
Distinguishing factors that contribute to poor outcomes for
children with malaria can inform clinical and programmatic
strategies to lessen its toll. However, research is limited by the
inherent challenges of conducting intrahospital epidemiologic
studies in rural centers where malaria prevalence is greatest.
We present results of a retrospective, time-matched, casecontrol study of hospitalized children with malaria who died
(cases) and those who survived (controls) at a rural, districtlevel hospital in a high-transmission region of northern Zambia
to identify and evaluate demographic and clinical factors associated with increased risk of death.

Severe malaria, caused by the protozoan Plasmodium, is
the leading parasitic cause of mortality worldwide. Plasmodium falciparum, the most lethal among human malaria parasites, predominates in sub-Saharan Africa where it causes a
disconcerting 1,200 child deaths per day concentrated in regions where malaria has proven recalcitrant to control measures or where control measures are tenuous or absent.1,2 In
Zambia, there were an estimated 3.1 million cases of malaria
(severe and uncomplicated) in 2016 among its population of
16.7 million and it was most prevalent in northern Zambia
where it persists year round despite the recent scale-up of
vector control efforts.2,3
Severe malaria can feature one or more of severe anemia
(hemoglobin < 5 g/dL), cerebral edema, lactic acidosis, respiratory failure, or shock. In high-transmission, resourcelimited settings, malaria evades easy case deﬁnition and is
often clinically indistinguishable from bacterial meningitis,
pneumonia, bacteremia, and other febrile diseases which can
conﬂate or confuse diagnosis.4 Only a small proportion (∼2%)
of P. falciparum infections progress to severe malaria, but in
highly malarious regions where children may experience
several infections a year, the absolute number of cases is
large.5 Prompt initiation of treatment is vital. Rapid disease
progression is fueled by an exponential expansion of parasites
and an exuberant host immune response, and hospital deaths
occur most often within 24 hours of admission.5,6 The preferred treatment is intravenous artesunate and supportive
care as indicated (e.g., ﬂuid resuscitation, blood transfusion,

METHODS
Study site. The study was conducted in Nchelenge District,
a high malaria transmission area of northern Zambia. Since
2012, the National Malaria Elimination Program under the
Ministry of Health have overseen bed net distributions and
indoor residual spray campaigns in the study area, although
little decrease in malaria burden has followed.3 Community
prevalence by rapid diagnostic tests is estimated to be
∼50%.8 In 2016, there were 1,128 adult and child hospital
admissions for malaria, accounting for 35% of all pediatric
hospital admissions and 38% of all pediatric deaths in the
hospital. The malaria case fatality rate was 80 and 65 deaths
per thousand adult and pediatric hospitalizations for malaria in
2016 and 2017, respectively.
A single 175-bed hospital staffed by three physicians and
one midlevel provider serves the district and surrounding
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areas. The hospital is a referral center for 11 rural health centers that lie 1.5 to > 40 km away, including an island community
30 km away. The rural health centers are neither outﬁtted with
the means to initiate speciﬁc therapy for severe malaria, which
includes intravenous artesunate, nor are alternatives such as
rectal artesunate and intramuscular artemether available.5
Children judged by health center providers to require care for
severe malaria are transferred to the hospital. Transportation
from health centers to the hospital is challenging: patients’
families must arrange transport for a fee, and road conditions
are poor.
Some patients do not survive transfer from the rural health
center to the hospital or from the hospital outpatient department to the ward, and are recorded in ward registers as
dead on arrival. Administration of intravenous artesunate,
blood transfusion, and other supportive care can only occur
once a child has been transferred to the ward.
Study design. This was a retrospective, time-matched,
case-control study of children with severe malaria admitted to
the hospital who died (cases) or survived (controls). Cases
were matched 1:1 with controls admitted on or near the same
date to account for differences in health-care providers,
stockouts of blood products or other hospital resources, and
other unmeasured temporal confounders such as road conditions, which vary between the rainy and dry seasons and
were hypothesized to impact time to treatment. If more than
one control was identiﬁed for a given day, the patient admitted
closest in time to the case was selected. The study was approved by the Johns Hopkins Bloomberg School of Public
Health Institutional Review Board as part of the International
Centers of Excellence for Malaria Research study and locally
by the Tropical Diseases Research Centre Ethics Review
Committee located in Ndola, Zambia.
Data collection. Case-control data were collected from
hospital registers and laboratory logbooks for children admitted to the hospital between January 2016 and October
2017. Severe malaria was determined by the discharge diagnosis in the register, and the primary outcome of the study
(survival or death) was determined by the recorded disposition
in the register. All patients admitted to the children’s ward with
severe malaria who died were included. Those who did not
survive were further stratiﬁed by those who died before
treatment could be administered (dead on arrival) and those
who died after they were admitted and underwent treatment.
Patient charts of children who died were frequently unavailable, precluding chart extraction of data.
Hospital epidemiologic data were collected from the hospital Health Management Information Systems database
(current to April 2017) and hospital registers. Distances from
villages to the hospital were provided by the district ofﬁce of
the Zambian Ministry of Health.
All hemoglobin values were presumed to be pretransfusion
values. Hospital practice is to require documented hemoglobin level before transfusion, and patients infrequently undergo
more than a single laboratory evaluation. We use the term
initial hemoglobin because not all children were subsequently
transfused (typical transfusion threshold is £ 5.0 g/dL).
Statistical analysis. Matched case-control data were analyzed by conditional logistic regression. Linear and logistic
regression models were applied for unmatched adjusted
analyses of early death. We hypothesized that the relationship
between village-to-hospital distance and survival would be

partially mediated by the degree of anemia as patients with
delayed presentation are more likely to have low mean hemoglobin concentrations due to disease progression. Mediation analysis was carried out to estimate the percent
contribution of hemoglobin concentration to the total indirect
effect of distance from the hospital on survival. Sensitivity
analyses were performed, one excluding patients from the two
most remote villages and their matched controls to account
for outlying distances and another introducing a covariate
designating admission during a blood stockout period to account for the ﬁve study pairs mismatched on that variable. A
subgroup analysis of patients who were dead on arrival to the
children’s ward was performed to examine risk factors of early
death. In a cross-sectional design, these patients were compared with cases who survived the initial admission period but
subsequently died. The frequencies of severe malaria hospitalization and death outcomes in relation to blood stockout
periods were analyzed using Poisson regression. Statistical
signiﬁcance was prespeciﬁed to a threshold P value of 0.05
and two-sided α. Analyses were carried out using Stata 14
(StataCorp, College Station, TX).
RESULTS
Study participants. We identiﬁed 126 children admitted to
the children’s ward with a diagnosis of severe malaria who
died during the period January 2016 through October 2017.
Most (89%) matched control patients were admitted within
1 day of the case patients, and of those, more than half (54%)
were admitted the same day. Eleven were admitted within
2 days of the matched control and three within 3 days. Five of
the 126 case-control pairs were mismatched on whether there
was a blood stockout on the day of admission. One case was
missing age and gender, but hemoglobin and village data were
available. Data on village distance to the hospital were available for all except nine control and 18 case patients. Hemoglobin concentrations were unavailable for 49 (39%) control
and 41 (33%) case children. Missingness was mainly due to
hemoglobin measurements done at rural health centers prior
to hospital transfer, hence results were not recorded in laboratory logbooks. Children whose hemoglobin measurements
were not available were similar in age, gender, and distance
from the hospital to those for whom hemoglobin data were
available.
Age, gender, hemoglobin, and severe anemia. There
were no statistically signiﬁcant differences in age, gender,
initial hemoglobin concentration, or prevalence of severe
anemia between children who survived and those who died
(Table 1). The median age of study children was 1 year
11 months, ranging from 2 months to 18 years. Slightly more
than half (53%) were girls. The mean initial hemoglobin concentration of all children was 5.4 g/dL (standard deviation 2.8
g/dL). Prevalence of severe anemia was 61% among cases
and 47% among controls, but the difference was not signiﬁcant after adjustment for age and gender (odds ratio [OR] 2.04,
95% conﬁdence interval [CI] 0.87–4.79, P = 0.10).
Distance from hospital. Children came from 73 villages
situated between 1.5 and 89.6 km from the hospital. One child
(control) lived within the hospital compound and one child
(case) was from the island community located 30 km away.
Those with severe malaria who did not survive were more
likely to come from distant villages than those who survived
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TABLE 1
Characteristics of children admitted to the hospital with a diagnosis of
severe malaria who died (cases) and survived (controls)
Characteristic

Cases

Controls

n = 126

n = 126

Female, n (%)
66 (52.8)
67 (53.2)
Age, months, median (IQR)
21 (12–36)
24 (13–36)
Hemoglobin concentration
5.0 (2.8)
5.8 (2.7)
(g/dL), mean (SD)*
Presence of severe anemia,
52 (61.2)
36 (46.8)
n (%)
Hemoglobin < 3 g/dL, n (%)
20 (23.5)
10 (13.0)
Distance from home village 13.5 (2.3–26.0) 3.2 (1.5–14.0)
to hospital (km), median
(IQR)
Presentation during blood
27 (21.4)
22 (17.5)
product stockout, n (%)

P Value

0.70
0.85
0.16
0.10
0.20
< 0.01
0.99

IQR = interquartile range; SD = standard deviation.
The P values were estimated by conditional logistic regression of matched case–control
data.
* Initial values measured on presentation.

(Figure 1). Adjusted for age and gender, every 1 km of distance
conferred a 4% increase in odds of death (OR 1.04, 95% CI
1.01–1.07, P < 0.01). Mediation analyses estimated that hemoglobin concentration accounted for only 4% of the contribution of distance from the hospital to death among all case
patients, and 28% among those recorded as dead on arrival to
the ward. In a sensitivity analysis excluding cases from the two
most outlying villages and their matched controls, the association between distance and death remained statistically
signiﬁcant (OR 1.04, 95% CI 1.01–1.07, P < 0.01). The same
was true when introducing a covariate for admission during a
stockout period to account for the ﬁve mismatched pairs.
Dead on arrival to ward. Among the 126 children with
severe malaria who died, 47 (37%) were dead on arrival to the
ward. Patients dead on arrival did not differ in age or gender
from those who died after arrival to the ward (Table 2). However, they came from more distant villages (median 14 versus
11 km, P = 0.05), anemia was more severe (mean hemoglobin
3.8 versus 5.6 g/dL, P = 0.01), and a higher proportion were
admitted when blood was unavailable for transfusion (31%
versus 17%, P = 0.03) (Table 2, Figure 2).
Blood inventory stockouts. Within the study period, there
were 12 whole blood stockouts ranging from 3 days to
3 weeks, totaling 68 days. Stockouts were more common
during months with greater-than-average daily pediatric

admissions for malaria (OR 7.1, 95% CI 4.5–11.3, P < 0.01).
During stockout periods, the incidence of death among children with malaria was once in 3 days, compared with one
death every 6 days during periods when blood was in supply
(daily mean number of deaths 0.30 versus 0.18, P = 0.02), but
the number of deaths as a proportion of admissions did not
differ (0.13 versus 0.13, P = 0.88).
DISCUSSION
This case-control study of children hospitalized with malaria
in a high-transmission setting of northern Zambia found that
the strongest predictor of mortality was distance from the
patient’s village to the hospital. Each kilometer of distance
from the hospital was accompanied by a 4% increase in the
odds of death. Low hemoglobin and hospitalization during
blood inventory stockouts were associated with early death,
deﬁned as those recorded as dead on arrival to the children’s
ward.
Distance to health centers is a well-documented risk factor
for child mortality in sub-Saharan Africa, although few studies
have examined its inﬂuence on malaria fatality.9–12 Long distance delays time to the ﬁrst dose of intravenous artesunate,
time to blood transfusion, and time to other supportive care.
Living a greater distance from the hospital may be associated
with other factors that affect malaria health outcomes, including delayed health-care–seeking behaviors.7,13
The young ages of the patients, and the prevalence and
profundity of anemia, were commensurate with a high malaria
transmission environment.14,15 In contrast to prior studies of
severe malaria conducted elsewhere in sub-Saharan Africa,
we did not ﬁnd an association between age and mortality, perhaps explained by the overall low median age of our study population (< 2 years) relative to previously studied populations.16–18
Most children (85%) were younger than 5 years and agerelated factors (e.g., premunition) may have been attenuated
because of the narrow age range of the study children.
Blood stockouts were more common during peaks in hospital admissions for malaria. The number of deaths among
hospitalized children with malaria was higher during stockout
periods, but modeling showed this to be explained wholly by
the increased number of admissions and not the depletion of
blood stores.
There were two unexpected ﬁndings related to the role of
anemia. First, we detected no signiﬁcant difference in

FIGURE 1. Distribution of home village-to-hospital distances among children with severe malaria who were hospitalized and died (cases) or
survived (controls).
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TABLE 2
Characteristics of children with severe malaria who were dead on arrival to the ward and those who died after arrival to the ward
Characteristic

Dead on arrival

Died after arrival

n = 47

n = 79

Female, n (%)
26 (55.3)
40 (51.3)
Age, months, median (IQR)
21 (12–36)
22 (12–36)
Hemoglobin concentration
3.8 (1.6)
5.6 (3.1)
(g/dL), mean (SD)*
Presence of severe anemia,
19 (73.1)
33 (55.9)
n (%)
Hemoglobin < 3 g/dL, n (%)
7 (26.9)
13 (22.0)
Distance from home village 14.0 (2.3–26.6) 11.0 (3.2–15.5)
to hospital (km), median
(IQR)
Presentation during blood
14 (31.1)
13 (16.5)
product stockout, n (%)

P Value

0.42
0.09
0.01
0.06
0.20
0.05
0.03

IQR = interquartile range; SD = standard deviation.
P values were estimated by logistic regression of cross-sectional (cases only) data.
* Initial values measured on presentation.

hemoglobin concentrations between those who survived and
those who died. Sample size limitations imposed by missingness in hemoglobin data and potential instances of misclassiﬁcation of the cause of death leading to artiﬁcial inﬂation
of the mean hemoglobin relative to controls are possible explanations for this ﬁnding. Based on data from a pivotal trial of
artesunate versus quinine for severe malaria,19 hemoglobin

appears to inﬂuence survival only at concentrations < 3 g/dL.20
Twice as many cases as controls in our sample had such low
hemoglobin concentrations, though the difference did not
reach the preset signiﬁcance threshold (P = 0.20).
The second unexpected ﬁnding was that hemoglobin
concentration explained only a small portion (4%) of the effect of distance on malaria death. We hypothesized that
greater distance from the hospital would correspond with
delay in presentation and thereby more profound anemia,
and ultimately a higher risk of death, as the illness progressed unchecked. Although we did not observe this in the
overall sample, the association was observed among children brought in dead to the ward. In these children, hemoglobin concentration accounted for > 25% of the estimated
effect of distance on death, consistent with the additional
ﬁnding of an association between children who were dead on
arrival to the ward and admission during a blood stockout
period. Hemoglobin testing and subsequent blood transfusion, if indicated and possible, are often done between the
time the child arrives to the hospital and is registered on the
ward. Our ﬁndings suggest that those who did not survive
the interval between presentation to the hospital and registration on the ward often died for lack of transfusion. These
represent children who never had the opportunity to receive
treatment and supportive care. Had they survived long
enough to undergo treatment, it is likely that some would

FIGURE 2. Outcomes of hospitalization among children with severe malaria admitted to the pediatric ward showing periods of blood product
stockouts.
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have recovered and survived to discharge, implying that
ensuring reliable blood inventories would improve malaria
survival.
There are limitations to this study. Reliance on hospital registers precluded a rigorous case deﬁnition of severe malaria and
death due to malaria, introducing potential misclassiﬁcation
bias. However, given the high background prevalence of malaria
in the catchment area, ready availability of malaria diagnostics,
and experienced hospital staff, we believe this is unlikely to have
signiﬁcantly inﬂuenced the study’s results. Furthermore, there is
precedent for our case deﬁnition; for example, the Severe
Malaria in African Children network enrolled any child with
malaria sick enough to be hospitalized.21 Similarly, we were
unable to ascertain clinical syndromes (e.g., cerebral malaria,
lactic acidosis) nor could we account for children with coinfections or incidental parasitemia unrelated to their illness. A
hospital-based study such as this is unable to account for
children who die at home from complications of malaria, die
at rural health centers or healers, or die en route to the hospital, who constitute most severe malaria deaths in some
settings.22,23 There are potential unmeasured confounders and
mediators of the effect of distance on malaria death, including
factors related to delays in care such as health-seeking behavior and knowledge, attitudes and practices around malaria,
time to ﬁrst dose of artesunate, and time to blood transfusion.
A precept of malaria control is prompt diagnosis and
treatment to reduce deaths from severe malaria and to diminish the infectious reservoir. National and local malaria
control programs prioritize surveillance of and response to
severe malaria morbidity and mortality, but these priorities are
often detrimentally overlooked by the research community
where clinical trials of interventions for severe malaria are
sparse and progress thereby slow.24 In the meantime, investments in transportation infrastructure (e.g., road improvements) to reduce transfer times to the hospital, hospital
triage systems that expedite treatment on arrival for patients
with severe malaria, and maintenance of responsive supply
chains for blood inventories to avert stockouts during periods
of high malaria incidence would temper case fatality. Stationing ambulances at remote health posts and furnishing
them with the capacity to initiate pre-transfer treatment of
severe malaria, such as intramuscular or rectal artesunate,
would be lifesaving.
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